Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cardiovascular disease

Questioning the effect of β-blockers on vascular stiffness

Assessment of arterial stiffness by pulse wave velocity can predict cardiovascular mortality in patients with renal failure. New research shows that atenolol is superior to lisinopril in reducing arterial stiffness in patients with hypertension undergoing haemodialysis. This finding might revive interest for further studies on vascular protection mediated by β-blockers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Chirinos, J. A. & Townsend, R. R. Reducing arterial stiffness in CKD: revising the paradigms. Clin. J. Am. Soc. Nephrol. 10, 547–550 (2015).

    Article  CAS  Google Scholar 

  2. Georgianos, P. I. & Agarwal, R. Effect of lisinopril and atenolol on aortic stiffness in patients on haemodialysis. Clin. J. Am. Soc. Nephrol. 10, 639–645 (2015).

    Article  CAS  Google Scholar 

  3. Dudenbostel, T. & Glasser, S. P. Effects of antihypertensive drugs on arterial stiffness. Cardiol. Rev. 20, 259–263 (2012).

    Article  Google Scholar 

  4. Shahin, Y., Khan, J. A. & Chetter, I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis 221, 18–33 (2012).

    Article  CAS  Google Scholar 

  5. Koumaras, C. et al. Effects of renin-angiotensin-aldosterone system inhibitors and β-blockers on markers of arterial stiffness. J. Am. Soc. Hypertens. 8, 74–82 (2014).

    Article  CAS  Google Scholar 

  6. Lindholm, L. H., Carlberg, B. & Samuelsson, O. Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 366, 1545–1553 (2005).

    Article  CAS  Google Scholar 

  7. Cockcroft, J. R. & Paedersen, M. E. β-blockade: benefits beyond blood pressure reduction? J. Clin. Hypertens. (Greenwich) 14, 112–120 (2012).

    Article  CAS  Google Scholar 

  8. Hayek, S. S. et al. Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor cells, and oxidative stress. J. Am. Soc. Hypertens. 9, 206–213 (2015).

    Article  CAS  Google Scholar 

  9. Kwan, B. C. et al. Effect of using ultrapure dialysate for haemodialysis on the level of circulating bacterial fragment in renal failure patients. Nephron Clin. Pract. 123, 246–253 (2013).

    Article  CAS  Google Scholar 

  10. Li, P. K. et al. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial. Clin. J. Am. Soc. Nephrol. 5, 652–658 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip Kam-Tao Li.

Ethics declarations

Competing interests

C.-C.S is a consultant for and receives research funding and consultancy from Baxter Healthcare. P.K.-T.L. declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Szeto, CC., Li, PT. Questioning the effect of β-blockers on vascular stiffness. Nat Rev Nephrol 11, 447–448 (2015). https://doi.org/10.1038/nrneph.2015.72

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2015.72

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing